SCHEMBL19080191

SCHEMBL19080191

c1cc(-c2c3ccccc3c(-c3ccc4c(c3)sc3ccccc34)c3ccccc23)cc(-c2cc3ccccc3c3c2oc2c4ccccc4c4ccccc4c23)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALOX5 P09917 2/20 0.32
GPR84 Q9NQS5 3/20 0.32
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
CASP1 P29466 1/20 0.31
HIF1A Q16665 1/20 0.31
HSD17B10 Q99714 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
S1PR4 O95977 3/20 0.31
S1PR5 Q9H228 3/20 0.31
NQO1 P15559 1/20 0.30
NQO2 P16083 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080187 0.86 ALDH1A1 (0.33) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL19080010 0.84 GPR84 (0.44) ALDH1A1HPGDMAPTSMN1; SMN2ALOX5
SCHEMBL19080169 0.82 ALOX5 (0.38) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL19080186 0.82 GPR3 (0.35) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL19079980 0.82 ALDH1A1 (0.38) ALDH1A1HPGDMAPTSMN1; SMN2ALOX5
SCHEMBL19080122 0.81 GPR84 (0.42) ALDH1A1HPGDALOX5GPR84TSHR
SCHEMBL19076695 0.80 F9 (0.33) ALDH1A1HPGDMAPTSMN1; SMN2GPR84
SCHEMBL18272713 0.80 ALDH1A1 (0.40) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL19080139 0.80 GPR84 (0.38) ALDH1A1HPGDMAPTSMN1; SMN2ALOX5
SCHEMBL19080184 0.77 PAX8 (0.32) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ALDH1A1 237/4885HPGD 1696/4885MAPT 1538/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ALDH1A1 237/4885HPGD 1696/4885MAPT 1538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.